Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

47.91
Delayed Data
As of Feb 10
 +1.33 / +2.86%
Today’s Change
42.41
Today|||52-Week Range
60.34
-17.51%
Year-to-Date

Today’s Trading

Previous close46.58
Today’s open48.55
Day’s range47.64 - 49.20
Volume4,300,742
Average volume (3 months)1,507,097
Market cap$93.4B
Dividend yield1.59%
Data as of 4:02pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)+6.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.53%
Revenue growth (last year)+5.60%
P/E ratio3.7
Price/Sales7.07
Price/Book18.45

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.21-0.53%
ABBVAbbVie-0.76-1.42%
SNYSanofi-0.38-0.98%
BMYBristol-Myers Squibb+0.06+0.10%
Data as of 4:02pm ET, 02/10/2016

Financials

Next reporting dateApril 29, 2016
EPS forecast (this quarter)$0.49
Annual revenue (last year)$15.7B
Annual profit (last year)$4.7B
Net profit margin29.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Gladsaxe, Capital Region

Forecasts

Partner Offers